Management of Pediatric Multidrug-Resistant Tuberculosis and Latent Tuberculosis Infections in New York City From 1995 to 2003
- 1 October 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 27 (10), 907-912
- https://doi.org/10.1097/inf.0b013e3181783aca
Abstract
Few studies have assessed the management and outcomes of multidrug-resistant tuberculosis (MDR-TB) in the pediatric population. Treatment of children with second-line TB drugs is complicated by potential toxicities of these agents. We performed a retrospective study of children <15 years of age treated for MDR-TB or MDR-latent TB infection (LTBI) from 1995 to 2003. We reviewed the New York City Department of Health and Mental Hygiene (DOHMH) computerized TB registry to characterize demographic characteristics, clinical presentations, treatment, and outcomes of the study subjects. Twenty subjects with MDR-TB (mean age 2.7 years) and 51 with MDR-LTBI (mean age 9.8 years) were studied. The most commonly used second-line TB drugs were cycloserine, quinolone agents, and ethionamide, which were used in 70%, 69%, and 54% of subjects, respectively. Sixteen (80%) of 20 MDR-TB and 38 (75%) of 51 MDR-LTBI cases completed treatment. A greater proportion of subjects receiving care at a DOH clinic completed treatment for LTBI (36/41, 88%), when compared with subjects treated at non-DOH sites [(2/9, 22%) P < 0.001]. Review of the TB registry indicated that no subjects had recurrent disease or progression of LTBI to active disease during the study period and for 2 years thereafter. Children with MDR-TB and LTBI were best cared for in public health settings. A multicenter registry for pediatric MDR-TB and MDR-LTBI would be desirable to obtain accurate rates of toxicity and cure.Keywords
This publication has 21 references indexed in Scilit:
- Community-Based Therapy for Children With Multidrug-Resistant TuberculosisPEDIATRICS, 2006
- Multidrug-Resistant Tuberculous Meningitis in Children in Durban, South AfricaThe Pediatric Infectious Disease Journal, 2006
- Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003JAMA, 2005
- Epidemiology of Childhood Tuberculosis in the United States, 1993–2001: The Need for Continued VigilancePEDIATRICS, 2004
- Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcomeArchives of Disease in Childhood, 2003
- Completeness of Pediatric TB Reporting in New York CityPublic Health Reports, 2003
- Molecular Epidemiology of Multidrug-Resistant Tuberculosis, New York City, 1995–1997Emerging Infectious Diseases, 2002
- Evaluation of Young Children in Contact With Adult Multidrug-Resistant Pulmonary Tuberculosis: A 30-Month Follow-upPEDIATRICS, 2002
- Multidrug-resistant tuberculosis in children: Two cases and a review of the literaturePediatric Pulmonology, 1996
- Tuberculosis in New York City — Turning the TideThe New England Journal of Medicine, 1995